1-9 of 9
Kerry Rogers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical and Economic Burden of Tumor Lysis Syndrome Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Kerry Rogers, Bruno Emond, Aurélie Côté-Sergent, Frédéric Kinkead, Marie-Hélène Lafeuille, Patrick Lefebvre, Qing Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4030.
https://doi.org/10.1182/blood-2021-148575
Published: 2021
Journal Articles

Characterization of Residual CLL Following Long-Term Bruton Tyrosine Kinase Inhibitor Therapy

Shanmugapriya Thangavadivel, Alexander Pan, Xi Chen, Chen Song, Claire Snyder, Kerry Rogers, Seema A Bhat, Adam S Kittai, Bradley W Blaser, James S. Blachly, Pearlly S. Yan, John C. Byrd, Jennifer A. Woyach
Journal: Blood
Blood (2021) 138 (Supplement 1): 2620.
https://doi.org/10.1182/blood-2021-154309
Published: 2021
Journal Articles

Evaluation of the Incidence and Risk Factors Associated with Bleeding Events in Patients Receiving Acalabrutinib Therapy

Pooja S. Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J. Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C. Byrd, Kerry Rogers, Jennifer A. Woyach, Adam S Kittai
Journal: Blood
Blood (2021) 138 (Supplement 1): 3729.
https://doi.org/10.1182/blood-2021-148719
Published: 2021
Journal Articles

Long-Term Results of Alliance A041202 Show Continued Advantage of Ibrutinib-Based Regimens Compared with Bendamustine Plus Rituximab (BR) Chemoimmunotherapy

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, Weiqiang Zhao, Allison M Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry Rogers, Sameer A. Parikh, Steven Coutre, Gerard Lozanski, Sreenivasa Nattam, Richard A. Larson, Harry P. Erba, Mark R. Litzow, James S. Blachly, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Jennifer R Brown, Richard F. Little, Scott E. Smith, Richard M. Stone, Sumithra J Mandrekar, John C. Byrd
Journal: Blood
Blood (2021) 138 (Supplement 1): 639.
https://doi.org/10.1182/blood-2021-153146
Published: 2021
Journal Articles

Normal FISH CLL Represents a Heterogeneous Subgroup Where Prognosis Can be Refined with IGHV Mutational Status

Cecelia Miller, Ying Huang, Jonathan Hyak, Matthew R Avenarius, Amy S. Ruppert, John C. Byrd, Seema A Bhat, Michael R Grever, Adam S Kittai, Kerry Rogers, Nyla A. Heerema, Lynne V. Abruzzo, Jennifer A. Woyach
Journal: Blood
Blood (2021) 138 (Supplement 1): 1563.
https://doi.org/10.1182/blood-2021-150722
Published: 2021
Journal Articles

Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL

Jennifer Woyach, MD, Shanmugapriya Thangavadivel, PhD, David Weiss, Lai Wei, PhD, Eric McLaughlin, MS, Kerry Rogers, Seema A. Bhat, MD, Michael R. Grever, MD, Michael Keller, Matthew Dort, Gerard Lozanski, MD, Barbara Andersen, PhD, John C. Byrd, MD, Farrukh T. Awan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1759.
https://doi.org/10.1182/blood-2019-131099
Published: 2019
Journal Articles

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

Jonathan E. Brammer, MD, Lubomir Sokol, MD PhD, Yutaka Tagaya, MD PhD, Kerry Rogers, Anjali Mishra, PhD, Thomas A. Waldmann, MD, Nazli Azimi, PhD PharmD, Paul Frohna, MD PhD PharmD, Anoshie Ratnayake, MD, Thomas P Loughran, Jr., MD, Karen Ballen, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2835.
https://doi.org/10.1182/blood-2019-129291
Published: 2019
Journal Articles

Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations

Jennifer Woyach, MD, Ying Huang, MS, MA, Kerry Rogers, Seema A. Bhat, MD, Michael R. Grever, MD, Arletta Lozanski, Tzyy-Jye Doong, James S. Blachly, MD, Gerard Lozanski, MD, Dan Jones, MD PhD, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 504.
https://doi.org/10.1182/blood-2019-127674
Published: 2019
Journal Articles

Ibrutinib and fungus: an invasive concern

Kerry Rogers
Journal: Blood
Blood (2018) 131 (17): 1882–1884.
https://doi.org/10.1182/blood-2018-02-832154
Published: 2018